About
Jeffrey M. Melin is a biopharma and healthcare physician whose public profile indicates an association with TOR Therapeutics. He appears in Johns Hopkins University's 2006 commencement records and is listed as an author on a publication about benefit-risk assessment of nonprescription drugs. Patent records also associate his name with rapamycin/metformin-related therapeutic compositions, suggesting involvement in biomedical innovation rather than investing.
Areas of interest
biopharmahealthcaredrug developmentdrug safetyoncology